Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort.

Key Result

Elevated Atherogenic Index of Plasma identifies anticoagulated patients with atrial fibrillation at increased thromboembolic and cardiovascular risk.

Key Points

• To evaluate the relationship between the atherogenic index of plasma and residual risk in anticoagulated patients with atrial fibrillation.
• Conducted a prospective cohort study within the Murcia Atrial Fibrillation Project III
• Assessed anticoagulated patients with atrial fibrillation
• Measured atherogenic index of plasma and evaluated thromboembolic and cardiovascular risks
• Elevated atherogenic index of plasma correlated with increased residual thromboembolic risk
• Patients with higher AIP displayed greater cardiovascular risk
• Study identifies a need for monitoring high-risk anticoagulated patients